Therapeutics Acquisition Corp. (RACA) Shareholders Approve POINT Biopharma Deal
by Marlena Haddad on 2021-06-30 at 6:45am

Therapeutics Acquisition Corp.  (NASDAQ:RACA) announced in an 8-K filing this morning that its shareholders approved its combination with radiopharmaceutical firm POINT Biopharma at a special meeting yesterday.

A not-insignificant number of shareholders opted to redeem their shares in connection with the vote, however. A total of 1,394,131 shares were redeemed, removing $13,941,310 from Therapeutic’s trust, or just over 10%. This is still not a bad result in the current market and should not interfere with the closing of the transaction, expected to come shortly. POINT is expected to trade on the Nasdaq under the symbol “PNT” following close.

Therapeutics initially announced the $639 million deal with POINT Biopharma on March 15. POINT is a clinical stage radiopharmaceutical firm researching the use of radioglands to treat cancer before and during chemotherapy.  POINT is ahead in its development timeline than many other biotech firms targeted by SPACs over the last six months as it already has two cancer therapies in Phase III trials with two more at preclinical stages.

All measures on Therapeutic’s ballot passed by wide margins, but for a full list of proposals and vote tallies, click HERE.


ADVISORS

  • Perella Weinberg Partners LP is acting as lead financial and capital markets advisor to POINT.
  • Cowen and Company, LLC and Piper Sandler are also acting as capital markets advisors to POINT.
  • Jefferies LLC is acting as lead financial and capital markets advisor to RACA.
  • Bass, Berry & Sims PLC is acting as lead legal counsel to POINT.
  • Goodwin Procter LLP is acting as lead legal counsel to RACA.
Recent Posts
by Nicholas Alan Clayton on 2024-03-28 at 1:35pm

News and Rumors PR: Bannix (NASDAQ:BNIX) has provided more information on the combination with VisionWave that it announced yesterday, specifying that the imaging technology that VisionWave will acquire from GBT Technologies will primarily seek out applications in military combat scenarios and geological surveys. PR: Grove Collaborative (NYSE:GROV), which combined with Virgin Group II in June...

by Nicholas Alan Clayton on 2024-03-28 at 7:47am

At the SPAC of Dawn Fed Chair Jerome Powell has given new hints that the administration would be showing greater levels of comfort with inflation if a cut could help improve unemployment numbers. Those numbers could get an update today at 8:30 am ET to bring new jobless claims as well as final prices for...

by Nicholas Alan Clayton on 2024-03-27 at 1:31pm

News and Rumors CNBC: Former WeWork (OTC Pink:WEWKQ) founder Adam Neumann has offered to buy back control of the company for $500 million but has yet to secure the necessary financing. WeWork went public with BowX in October 2021. PR: Satellite telecom firm Spire Global (NYSE:SPIR) has signed an agreement to build and launch two...

by Nicholas Alan Clayton on 2024-03-27 at 11:38am

Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...

by Nicholas Alan Clayton on 2024-03-27 at 7:33am

At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved